新入荷
再入荷
Safety, tolerability and weight reduction findings of oral amycretin: a novel amylin and glucagon-like peptide-1 receptor co-agonist, in a first-in-human study - Media Centre | EASD
4.3
（5件）
タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料（※）
999円以上お買上げで代引き手数料無料
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
商品詳細情報
| 管理番号 |
新品 ：3434330521
中古 ：3434330521-1 |
メーカー | 7bf18495b1e | 発売日 | 2025-04-14 15:12 | 定価 | 14000円 | ||
|---|---|---|---|---|---|---|---|---|---|
| カテゴリ | |||||||||
Safety, tolerability and weight reduction findings of oral amycretin: a novel amylin and glucagon-like peptide-1 receptor co-agonist, in a first-in-human study - Media Centre | EASD
Safety, tolerability and weight reduction findings of oral amycretin: a novel amylin and glucagon-like peptide-1 receptor co-agonist, in a first-in-human study - Media Centre | EASD,E-SPECIAL Eye Stretch Serum [18 mL],Amy Hannaford - Life Sciences Senior Manager - Wavestone | LinkedIn,Safety, tolerability and weight reduction findings of oral amycretin: a novel amylin and glucagon-like peptide-1 receptor co-agonist, in a first-in-human study - Media Centre | EASD,E-SPECIAL Eye Stretch Serum [18 mL]
健康・医学の作品リスト
レディースの製品
